RSS-Feed abonnieren
DOI: 10.1055/s-0028-1109267
© Georg Thieme Verlag KG Stuttgart · New York
Acute Massive Suprachoroidal Hemorrhage after Photodynamic Therapy in a Patient Treated with Warfarin[1]
Akute massive suprachorioidale Blutung nach photodynamischer Therapie bei einer Warfarin-PatientinPublikationsverlauf
Publikationsdatum:
21. April 2009 (online)

Age-related macular degeneration (AMD) is the leading cause of legal blindness in the elderly in industrialized nations. Anti-VEGF therapy has become the treatment of choice helping to preserve vision in a great percentage of patients with exudative AMD [8], yet photodynamic therapy (PDT) remains an effective treatment for predominantly classic choroidal neovascularization (CNV) and small occult with no classic CNV with recent disease progression.
PDT has a safe profile and adverse events are generally not seen [2]. We describe a case of acute massive suprachoroidal hemorrhage soon after PDT in a patient treated with warfarin.
1 1Presented at the 101st Annual Congress of the SOG/SSO, Interlaken 10. – 13.9.2008.
References
- 1
Alexandrakis G, Chaudhry N A, Liggett P E. et al .
Spontaneous suprachoroidal hemorrhage in age-related macular degeneration presenting
as angle-closure glaucoma.
Retina.
1998;
18
485-486
MissingFormLabel
- 2
Azab M, Benchaboune M, Blinder K J. et al .
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular
degeneration: meta-analysis of 2-year safety results in three randomized clinical
trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and
Verteporfin In Photodynamic Therapy Study Report no. 4.
Retina.
2004;
24
1-12
MissingFormLabel
- 3
Beyer C F, Peyman G A, Hill J M.
Expulsive choroidal hemorrhage in rabbits: A histopathologic study.
Arch Ophthalmol.
1989;
107
1648-1653
MissingFormLabel
- 4
Chaudhry N A, Lavaque N A, Tom D E. et al .
Large submacular hemorrhage following PDT with verteporfin in patients with occult
CNVM secondary to age-related macular degeneration.
Ophthalmic Surg Lasers Imaging.
2007;
38
64-68
MissingFormLabel
- 5
Chieh J J, Fekrat S.
Large submacular hemorrhage after intravitreal bevacizumab (Avastin) for age-related
macular degeneration.
Ann Ophthalmol (Skokie).
2007;
39
51-52
MissingFormLabel
- 6
Ghu T G, Green R L.
Suprachoroidal hemorrhage.
Surv Ophthalmol.
1999;
43
471-486
MissingFormLabel
- 7
Pournaras C J, Logean E, Riva C E. et al .
Regulation of subfoveal choroidal blood flow in age-related macular degeneration.
Invest Ophthalmol Vis Sci.
2006;
47
1581-1586
MissingFormLabel
- 8
Rosenfeld P J, Brown D M, Heier J S. et al .
Ranibizumab for neovascular age-related macular degeneration.
N Engl J Med.
2006;
355
1419-1431
MissingFormLabel
- 9
Schmidt-Erfurth U, Hasan T.
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of
age-related macular degeneration.
Surv Ophthalmol.
2000;
45
195-214
MissingFormLabel
- 10
Tilanus M A, Vaandrager W, Cuypers M H. et al .
Relationship between anticoagulant medication and massive intraocular hemorrhage in
age-related macular degeneration.
Graefe’s Arch Clin Exp Ophthalmol.
2000;
238
482-485
MissingFormLabel
- 11
Ung T, James M, Gray R H.
Long term warfarin associated with bilateral blindness in a patient with atrial fibrillation
and macular degeneration.
Heart.
2003;
89
985
MissingFormLabel
1 1Presented at the 101st Annual Congress of the SOG/SSO, Interlaken 10. – 13.9.2008.
John M. Katsimpris
Ritsou & Empeirikou Street 73
26335 Patras
Greece
Telefon: + + 30/26 10/64 34 97
Fax: + + 30/26 10/64 34 97
eMail: jkatsimpris@yahoo.com